EP3893785A4 - Compositions and methods for treating wounds - Google Patents

Compositions and methods for treating wounds Download PDF

Info

Publication number
EP3893785A4
EP3893785A4 EP19895776.3A EP19895776A EP3893785A4 EP 3893785 A4 EP3893785 A4 EP 3893785A4 EP 19895776 A EP19895776 A EP 19895776A EP 3893785 A4 EP3893785 A4 EP 3893785A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
treating wounds
wounds
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19895776.3A
Other languages
German (de)
French (fr)
Other versions
EP3893785A1 (en
Inventor
Linda Black
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CP Medical Corp
Original Assignee
CP Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CP Medical Corp filed Critical CP Medical Corp
Publication of EP3893785A1 publication Critical patent/EP3893785A1/en
Publication of EP3893785A4 publication Critical patent/EP3893785A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0019—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
    • A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
EP19895776.3A 2018-12-10 2019-12-10 Compositions and methods for treating wounds Withdrawn EP3893785A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862777354P 2018-12-10 2018-12-10
PCT/US2019/065362 WO2020123436A1 (en) 2018-12-10 2019-12-10 Compositions and methods for treating wounds

Publications (2)

Publication Number Publication Date
EP3893785A1 EP3893785A1 (en) 2021-10-20
EP3893785A4 true EP3893785A4 (en) 2022-08-17

Family

ID=71076249

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19895776.3A Withdrawn EP3893785A4 (en) 2018-12-10 2019-12-10 Compositions and methods for treating wounds

Country Status (7)

Country Link
US (1) US20210322785A1 (en)
EP (1) EP3893785A4 (en)
JP (1) JP2022516585A (en)
CN (1) CN113226211A (en)
AU (1) AU2019396194A1 (en)
CA (1) CA3122565A1 (en)
WO (1) WO2020123436A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115177779B (en) * 2022-06-14 2023-12-05 深圳凡旻生物科技有限公司 Biological glue and preparation method and application thereof
CN115814163B (en) * 2022-06-27 2023-09-29 北京博辉瑞进生物科技有限公司 PEG bi-component self-adhesive absorbable biological patch, and preparation method and application thereof
CN116077744A (en) * 2022-08-05 2023-05-09 清华大学 Absorbable self-developing hydrogel and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6454791B1 (en) * 1994-03-21 2002-09-24 Marvin A. Prescott Laser therapy for foot conditions
WO2014197847A1 (en) * 2013-06-07 2014-12-11 The Regents Of The University Of California Methods and systems of treating wounds
US20170209348A1 (en) * 2014-06-24 2017-07-27 Klox Technologies Inc. Biophotonic compositions comprising halogen and uses thereof
US20180050129A1 (en) * 2013-03-14 2018-02-22 Medicus Biosciences Llc Biocompatible hydrogel polymer matrix for delivery of cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505726A (en) * 1994-03-21 1996-04-09 Dusa Pharmaceuticals, Inc. Article of manufacture for the photodynamic therapy of dermal lesion
US20080215020A1 (en) * 2007-01-22 2008-09-04 Reeves William H Apparatuses and methods for healing wounds
WO2011031977A1 (en) * 2009-09-11 2011-03-17 Follica, Inc. Intermittent and pulse lithium treatments for scar revision and wound healing
US20150029307A1 (en) * 2010-06-09 2015-01-29 Elias Haralabos Method and device for improved ulcer treatment
DE102016125579A1 (en) * 2016-12-23 2018-06-28 Paul Hartmann Ag Hydrous hydrogel composition comprising elemental silver particles
US20210228720A1 (en) * 2018-06-05 2021-07-29 Klox Technologies Inc. Absorbent biophotonic fiber system
WO2020010238A1 (en) * 2018-07-05 2020-01-09 Preco, Inc. Laser processing hydrogel materials
US11896724B2 (en) * 2019-10-07 2024-02-13 Arizona Board Of Regents On Behalf Of Arizona State University Bioactive polymeric dressing for accelerated wound closure

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6454791B1 (en) * 1994-03-21 2002-09-24 Marvin A. Prescott Laser therapy for foot conditions
US20180050129A1 (en) * 2013-03-14 2018-02-22 Medicus Biosciences Llc Biocompatible hydrogel polymer matrix for delivery of cells
WO2014197847A1 (en) * 2013-06-07 2014-12-11 The Regents Of The University Of California Methods and systems of treating wounds
US20170209348A1 (en) * 2014-06-24 2017-07-27 Klox Technologies Inc. Biophotonic compositions comprising halogen and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020123436A1 *

Also Published As

Publication number Publication date
EP3893785A1 (en) 2021-10-20
WO2020123436A1 (en) 2020-06-18
CN113226211A (en) 2021-08-06
US20210322785A1 (en) 2021-10-21
CA3122565A1 (en) 2020-06-18
JP2022516585A (en) 2022-02-28
AU2019396194A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
EP3947715A4 (en) Methods and compositions for treating cancer
EP3612215A4 (en) Compositions and methods for treating lung inflammation
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
EP3829299A4 (en) Bismuth-thiol compositions and methods for treating wounds
EP3423100A4 (en) Compositions for treating inflammation and methods of treating the same
EP3931336A4 (en) Compositions and methods for treating laminopathies
EP3801478A4 (en) Methods and compositions for preventing or treating calciphylaxis
EP3893785A4 (en) Compositions and methods for treating wounds
EP3413881A4 (en) Compositions and methods for treating chronic wounds
EP3773585A4 (en) Compositions and methods for treating cancer
EP3773539A4 (en) Compositions for treating skin
EP3691649A4 (en) Compositions and methods for wound treatment
EP3600291A4 (en) Compositions and methods for treating synucleinopathies
EP3823593A4 (en) Compositions and methods for treating autism
EP3836941A4 (en) Methods and compositions for treating mucositis
EP3755328A4 (en) Compositions and methods for treating pruritus
AU2018301500A1 (en) Methods and compositions for treating inflammation
EP3638287A4 (en) Methods and compositions for treating microbial inflammation
EP3595640A4 (en) Compositions and methods for treating multiple sclerosis
EP3999076A4 (en) Compositions and methods for treating skin conditions
EP3886888A4 (en) Compositions and methods for treating glioma
EP3758692A4 (en) Compositions and methods for treating pain
EP3902917A4 (en) Compositions and methods for treating cancer
EP3849561A4 (en) Compositions and methods for enhancing wound healing
EP3877514A4 (en) Compositions and methods for treating cancer

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210630

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220719

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 5/06 20060101ALI20220713BHEP

Ipc: A61L 27/52 20060101ALI20220713BHEP

Ipc: A61L 27/50 20060101ALI20220713BHEP

Ipc: A61L 27/18 20060101ALI20220713BHEP

Ipc: A61L 26/00 20060101ALI20220713BHEP

Ipc: A61B 18/20 20060101AFI20220713BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230216